One of the highlights of Eli Lilly's third-quarter results ... described as "viral" take-up by the drugmaker. Lilly's head of diabetes, Mike Mason, said on the company's results call that the ...
Two years ago, Eli Lilly started working with Dexcom ... insulin therapy is still overwhelming and complex,” said Mike Mason, who heads Lilly’s connected care and insulins programme.